Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

NCT05760560 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05760560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2023
Completion date
August 31, 2024
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative residual curarization